Dr Helen McGettrick PhD, MSc, BSc

Dr Helen McGettrick

Institute of Inflammation and Ageing
Arthritis Research UK Career Development Fellow

Contact details

Institute of Inflammation and Ageing
College of Medical and Dental Sciences
University of Birmingham
B15 2TT

Helen McGettrick is an experimental biologist who specialises in developing multi-cellular in vitro models to examine the processes by which tissue resident cells influence leukocyte adhesion and migration during inflammation. Find out more

Helen’s research focuses on leukocyte recruitment and stromal cell biology in health and disease, in which she has several publications. She is currently using this expertise in the fields of rheumatology, diabetes, stem cell biology and cancer biology. She has received grants from Arthritis Research UK, in the form of a Career Development Fellowship, Wellcome Trust, British Heart Foundation, Enterprise Birmingham Fund, and Pfizer.

Video clipFrustrated migration of human peripheral blood lymphocytes on cytokine-stimulated endothelium:
During inflammation, lymphocytes migrate over the surface (white, bright cells), through and underneath (dark cells) activated endothelial cells to enter the tissue. If the lymphocytes do not receive an appropriate signal, their migration becomes frustrated, as they transit into and out of the endothelial monolayer searching for it.


  • PhD in Medical Science - University of Birmingham, 2006
  • MSc in Immunology – Distinction, University of Birmingham, 2002
  • BSc (Hons) in Biochemistry - First Class, University of Lancaster, 2001


Helen graduated from the University of Lancaster in 2001 with a BSc (Hons) in Biochemistry, during this course she spent a year studying aboard at Oregon State University, USA. She obtained a MSc. in Immunology from the University of Birmingham in 2002, undertaking a research project looking at neutrophil apoptosis (cell death) with Janet Lord and Dagmar Scheel-Toellner in the School of Immunity and Infection. She subsequently joined Gerard Nash’s Cardiovascular Rheology Group in the School of Clinical and Experimental Medicine, where she completed her PhD in Medical Sciences in 2006.

Helen has continued to work in Birmingham investigating the processes controlling leukocyte recruitment and fate both in health and disease, focusing on the role of the tissue microenvironment. She was appointed as a University Fellow in Inflammation Biology within the System Science for Health multidisciplinary translational research consortium at Birmingham in 2011.

In 2012, Helen was awarded an Arthritis Research Career Development Fellowship to explore the role of synovial fibroblasts in regulating leukocyte accumulation during the development of persistent arthritis.

Helen is currently organising the 27th UK Cell Adhesion Society Meeting to be held in September 2015 at the University of Birmingham.



Previous undergraduate research projects

  • Fibroblasts regulate inflammation: What changes in early rheumatoid arthritis to make it persist? (2015)
  • Characterising the ability of mesenchymal stem cell-derived adipocytes and osteoblasts to influence leukocyte recruitment to vascular endothelial cells (2015)
  • Investigating how platelets influence the recruitment of mesenchymal stem cells from the blood (2015)
  • Examining the immunomodulatory properties of MSC (2014)
  • Characterising the ability of mesenchymal stem cells to influence the migration of leukocytes through vascular endothelial cells (2013)
  • How do lymphatic endothelial cells influence lymphocyte migration during inflammation? (2013)
  • Establishing the role of CD248 in influencing PDGF signalling during angiogenesis (2012-2013)
  • Characterising the process of leukocyte migration through lymphatic endothelium:  which leukocytes can exit tissue? (2012)
  • Characterising new steps in T-cell migration into tissue during inflammation (2011)
  • Characterisation of a new regulatory step in T-cell penetration of tissue during inflammation (2010)

Previous summer research projects

  • Improving engineered tissue constructs for compatibility with human leukocytes (2014)
  • Characterising how MSC influence leukocyte migration through endothelium  using novel in vitro constructs (2013).
  • Developing an in vitro construct to model the entry and exit of lymphocytes in inflamed tissue (2013).

Postgraduate supervision

Helen currently supervises PhD students on the following projects:

  • MSC as endogenous regulators of inflammation: Changes in chronic inflammation. Lewis Clarke (Oct 2014).
  • Manipulating the immunomodulatory effects of mesenchymal stem cells. Hafsa Munir (Oct 2012-present).

Find a PhD - http://www.findaphd.com/search/ProjectDetails.aspx?PJID=53722&LID=139

Previous Masters projects

  • Examining the immunomodulatory capacity of mesenchymal stem cells: Is there a role for metabolites? (Oct 2014-Mar 2015)
  • Examining the impact of migration on T cell function (May-Aug 2014).
  • Characterising the effects of chronic inflammation on the phenotype of MSC (May-Aug 2014).
  • Mesenchymal stem cells as modulators of neutrophil recruitment (Jan-Apr 2014).
  • A new regulatory step in T-cell migration into tissue during inflammation; separating the wanted from the unwanted (May-Aug 2011).


Helen’s research concentrates on the concept that the state of the local tissue (stromal) microenvironment defines the responsiveness of endothelial cells, and also the subsequent fate of recruited leukocytes. This has involved the development and validation of novel in vitro, multi-cellular, multi-layered static and flow-based culture systems. Her goal is to develop a more complete understanding of the molecular circuitry regulating tissue migration and egress during acute and chronic inflammation reactions, with a view to developing anti-inflammatory, pro-resolution therapeutic strategies. A novel approach that we are investigating is to manipulate the local stroma to instruct recruited cells to leave chronically inflamed tissue, in effect to “switch on” resolution, or alternatively to stop leukocytes entering the inflamed site by “turning off” recruitment.


Chronic Inflammation – Rheumatoid Arthritis

  • Fibroblast-endothelial cell crosstalk regulating lymphocyte recruitment in resolving and persistent arthritis
  • Adiponectin-PEPITEM axis  and regulation of T-cell migration in Rheumatoid Arthritis

Mesenchymal Stem Cells

  • Immunomodulatory effects of mesenchymal stem cells on leukocyte recruitment and vascular inflammation
  • Modulation of mesenchymal stem cell responses by their local microenvironment

Regulation of Migration

  • Vascular-lymphatic endothelial cell crosstalk and leukocyte exit from tissue
  • Multi-cellular 3-D in vitro models examining the migration, fate and function of leukocytes entering inflamed tissue


Principle Investigator

2015-2017 - Pfizer
Defining the therapeutic potential of a novel peptide regulator of T-cell recruitment in rheumatoid arthritis

2014-2016 - Enterprise Birmingham Fund
Demonstrating the utility of a biomarker to detect Rheumatoid Arthritis at a very early pre-symptomatic stage.

2012-2017 – Arthritis Research UK Career Development Fellowship
Exploring the role of synovial fibroblasts in regulating leukocyte accumulation during the development of persistent arthritis.

2009 – Wellcome Trust VIP Fellowship
Regulation of lymphocyte migration and retention by the stromal microenvironment.


2015-2018 – British Heart Foundation
Mechanisms, optimisation, and in vivo application of the vascular protective effects of mesenchymal stem cells.

2010-2012 – Wellcome Trust
Role of fibroblasts in induction of tissue-specific recruitment of memory T-cell subsets.

Other activities

Editoral Board

  • Scientific Reports (2015 - present) 
  • Annals of Autoimmunity and Research

Committee Membership

Conference Organisation

  • 27th UK Cell Adhesion Society Meeting - Birmingham, 2015
  • 2nd BSI Leukocyte Migration Affinity Group - Birmingham, 2015
  • 26th UK Adhesion Society - Birmingham, 2013
  • 24th UK Adhesion Society - Birmingham, 2011
  • British Microvascular Society - Workshop - Birmingham, 2009

Membership and Affiliation

  • Fellow of the Higher Education Academy
  • British Society of Immunology
  • Society of Leukocyte Biology


Recent Peer Reviewed Publications

M. Chimen*, H.M. McGettrick*, B. Apta, J.S. Kuravi, C.M. Yates, A. Kennedy, A. Odedra, M. Alassiri, M. Harrsion, A. Martin, F. Barone, S. Nayar, J.R. Hitchcock, A.F. Cunningham, K. Raza, A. Filer, D.A. Copland, A.D. Dick, J. Robinson, N. Kalia, L.S.K. Walker, C.D. Buckley, G.B. Nash, P. Narendran and G.E. Rainger. (2015). Homeostatic regulation of T cell trafficking by a B cell derived peptide is impaired in autoimmune and chronic inflammatory disease. Nature Medicine Epub doi:10.1038/nm.3842(* joint authorship)

D. Luo, H.M. McGettrick, PC, Stone PC, GE, Rainger GE and GB Nash (2015) The roles of Integrins in function of Human Neutrophils after their migration through endothelium into interstitial matrix. PloS One 10(2):e0118593

H. Munir, G.E. Rainger, G.B. Nash, and H.M. McGettrick. (2014) Analysing the effects of stromal cells on the recruitment of leukocytes from flow. Journal of Visualised Experiments.95:e52480, doi:10.3791/52480 (http://www.jove.com/video/52480

 A. Zalli, N. Riddell, H.M.McGettrick, and P. Moss, G.R. Wallace (2014). Targeting 2-adrenergic receptors regulates T-cell function directly and indirectly.Brain Behaviour and Immunity, S0889-1591(14)00563-7. doi: 10.1016/j.bbi.2014.12.001

 A. Naylor*, H.M. McGettrick*, W. Maynard, P. May, F. Barone, A. Croft, S. Egginton and C.D. Buckley (2014).A differential role for CD248 (Endosialin) in different forms of physiological angiogenesis in skeletal muscle. PLoS One 9:e107146 (* joint authorship)

 J.S. Kuravi*, H.M. McGettrick*, S.C. Satchell, M.A. Saleem, L. Harper, J.M. Williams, G.E. Rainger and C.O. Savage (2014). Podocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6 mediated cross-talk. Journal of Immunology 193:234-243 (* joint authorship)

Recent Reviews

H. Munir and H.M. McGettrick. (2015).Mesenchymal stem cell therapy for autoimmune disease: risks and rewards. Stem Cells and Development, 24:2091-100

 H.M. McGettrick, L.M. Butler, C.D. Buckley and G.E. Rainger and G.B. Nash. (2012). Stromal tissue as a regulator of leukocyte recruitment in inflammation. Journal of Leukocyte Biology, 91:385-400

Full listing of publications